Klaus Frueh
Presidente en Tomegavax, Inc. .
Perfil
Klaus Frueh is the founder of Vir Biotechnology, Inc. which was founded in 2016.
He held the title of Director from 2016 to 2019.
Currently, Dr. Frueh is the President & Secretary at Tomegavax, Inc.
Cargos activos de Klaus Frueh
| Empresas | Cargo | Inicio |
|---|---|---|
Tomegavax, Inc.
 Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | Presidente | - |
Antiguos cargos conocidos de Klaus Frueh.
| Empresas | Cargo | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Fundador | 16/10/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Tomegavax, Inc.
Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | Commercial Services |
- Bolsa de valores
- Insiders
- Klaus Frueh
